Mukka Proteins Limited — Others, 18-11-2024: Shareholders meeting

Mukka Proteins Limited has conducted its Extra-Ordinary General Meeting (EGM) on November 16, 2024, where shareholders approved two key resolutions. Firstly, there was a successful vote to increase the authorized share capital, with 99.99% of shareholders voting in favor. Secondly, the company received overwhelming support for raising funds via the issuance of equity shares, achieving nearly unanimous approval of 99.998%.

This significant approval positions Mukka Proteins to expand its capital base, potentially facilitating future growth opportunities. The outcomes should bolster investor confidence, reflecting a positive outlook as the company embarks on new financing initiatives.